Study follows PEP for sexual exposures.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003376:Counseling; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D012307:Risk Factors; D012725:Sexual Behavior; D015819:Substance Abuse, Intravenous
D019380:Anti-HIV Agents